195 related articles for article (PubMed ID: 32699939)
1. PD-L1 expression in tongue squamous cell carcinoma.
Akisada N; Nishimoto K; Takao S; Gion Y; Marunaka H; Tachibana T; Makino T; Miki K; Akagi Y; Tsumura M; Toji T; Yoshino T; Nishizaki K; Orita Y; Sato Y
Med Mol Morphol; 2021 Mar; 54(1):52-59. PubMed ID: 32699939
[TBL] [Abstract][Full Text] [Related]
2. APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.
Wang J; Lun L; Jiang X; Wang Y; Li X; Du G; Wang J
Int Immunopharmacol; 2021 Aug; 97():107675. PubMed ID: 33964809
[TBL] [Abstract][Full Text] [Related]
3. Significance of PD-L1 Expression in Tongue Cancer Development.
Yoshida S; Nagatsuka H; Nakano K; Kogashiwa Y; Ebihara Y; Yano M; Yasuda M
Int J Med Sci; 2018; 15(14):1723-1730. PubMed ID: 30588196
[No Abstract] [Full Text] [Related]
4. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence.
Naruse T; Yanamoto S; Okuyama K; Ohmori K; Tsuchihashi H; Furukawa K; Yamada SI; Umeda M
Pathol Oncol Res; 2020 Apr; 26(2):735-742. PubMed ID: 30767115
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of programmed cell death ligand-1 expression in head and neck cancer treated with programmed cell death protein-1/programmed cell death ligand-1 inhibitors: A meta-analysis based on clinical trials.
Huang Z; Zheng S; Ding S; Wei Y; Chen C; Liu X; Li H; Xia Y
J Cancer Res Ther; 2021 Jul; 17(3):676-687. PubMed ID: 34269299
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
9. Overall survival and PD-L1 expression in patients with recurrent or metastatic head and neck cancer treated with nivolumab.
Okamoto I; Sato H; Tsukahara K
Auris Nasus Larynx; 2020 Aug; 47(4):676-686. PubMed ID: 32439271
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and Prognostic Analysis of PD-L1 and PD-L2 Expression in Surgically Resected Primary Tongue Squamous Cell Carcinoma.
Furukawa K; Kawasaki G; Yoshida T; Umeda M
Anticancer Res; 2021 Jan; 41(1):101-111. PubMed ID: 33419803
[TBL] [Abstract][Full Text] [Related]
11. Histopathological Subtypes and PD-L1 Expression in Primary Urethral Adenocarcinoma: A Series of 5 Cases.
Padilla-Ansala C; García-Fernández E; González-Peramato P
Int J Surg Pathol; 2021 Aug; 29(5):488-495. PubMed ID: 33463392
[TBL] [Abstract][Full Text] [Related]
12. Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs.
Ahmadvand S; Norouzi LA; Mohammadi Y; Safaei A; Khademi B; Motiee-Langroudi M; Ghaderi A
BMC Immunol; 2024 Jan; 25(1):7. PubMed ID: 38229027
[TBL] [Abstract][Full Text] [Related]
13. HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings.
Boschert V; Teusch J; Aljasem A; Schmucker P; Klenk N; Straub A; Bittrich M; Seher A; Linz C; Müller-Richter UDA; Hartmann S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233528
[TBL] [Abstract][Full Text] [Related]
14. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
Front Immunol; 2021; 12():645170. PubMed ID: 33897693
[TBL] [Abstract][Full Text] [Related]
15. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X
Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of PD-1/PD-L1 axis expression in patients with tongue squamous cell carcinoma.
Huang W; Zhou X; Liao Q; Tang Y; Zuo L; Wang H; Chen X; Chen X; Li J; Zhu S; Deng J; Liu Y; Zhu K; Yu J; Xiong W
J Cell Physiol; 2020 Oct; 235(10):6942-6953. PubMed ID: 32030768
[TBL] [Abstract][Full Text] [Related]
17. Expression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance.
Chen SW; Li SH; Shi DB; Jiang WM; Song M; Yang AK; Li YD; Bei JX; Chen WK; Zhang Q
Int J Biol Markers; 2019 Dec; 34(4):398-405. PubMed ID: 31674884
[TBL] [Abstract][Full Text] [Related]
18. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 Expression and Survival Rates Using TPS and CPS for Nivolumab-treated Head-and-Neck Cancer.
Ito T; Okamoto I; Tokashiki K; Sato H; Okada T; Yamashita G; Nagao T; Hirai H; Saigusa N; Tsukahara K
Anticancer Res; 2022 Mar; 42(3):1547-1554. PubMed ID: 35220251
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
Chen K; Cheng G; Zhang F; Zhang N; Li D; Jin J; Wu J; Ying L; Mao W; Su D
Oncotarget; 2016 May; 7(21):30772-80. PubMed ID: 27120796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
